DNM2 and breast carcinoma: Up-regulation of the cytoskeletal protein cortactin/EMS1, a relatively specific substrate of c-Src [34–36], has been reported to be involved in metastases [55] and correlated with poor outcomes of patients with breast cancer [56, 57].